Objective: Although twin and family studies have shown attention-deficit/hyperactivity disorder (ADHD) to be highly heritable, genetic variants influencing the trait at a genome-wide significant level have yet to be identified. As prior genome-wide association studies (GWAS) have not yielded significant results, we conducted a meta-analysis of existing studies to boost statistical power.
Method: We used data from four projects: a) the Children's Hospital of Philadelphia (CHOP); b) phase I of the International Multicenter ADHD Genetics project (IMAGE); c) phase II of IMAGE (IMAGE II); and d) the Pfizer-funded study from the University of California, Los Angeles, Washington University, and Massachusetts General Hospital (PUWMa). The final sample size consisted of 2,064 trios, 896 cases, and 2,455 controls. For each study, we imputed HapMap single nucleotide polymorphisms, computed association test statistics and transformed them to z-scores, and then combined weighted z-scores in a meta-analysis.
Results: No genome-wide significant associations were found, although an analysis of candidate genes suggests that they may be involved in the disorder.
Conclusions: Given that ADHD is a highly heritable disorder, our negative results suggest that the effects of common ADHD risk variants must, individually, be very small or that other types of variants, e.g., rare ones, account for much of the disorder's heritability.
2010 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):898-905.e3. doi: 10.1016/j.jaac.2010.02.014. Epub 2010 May 14. J Am Acad Child Adolesc Psychiatry. 2010. PMID: 20732626 Free PMC article. Clinical Trial.
Case-control genome-wide association study of attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):906-20. doi: 10.1016/j.jaac.2010.06.007. Epub 2010 Aug 5. J Am Acad Child Adolesc Psychiatry. 2010. PMID: 20732627 Free PMC article. Clinical Trial.
A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts.J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):896-905.e6. doi: 10.1016/j.jaac.2016.05.025. Epub 2016 Aug 5. J Am Acad Child Adolesc Psychiatry. 2016. PMID: 27663945 Free PMC article.
Twin studies and their implications for molecular genetic studies: endophenotypes integrate quantitative and molecular genetics in ADHD research.J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):874-83. doi: 10.1016/j.jaac.2010.06.006. Epub 2010 Jul 31. J Am Acad Child Adolesc Psychiatry. 2010. PMID: 20732624 Free PMC article. Review.
Genome-wide association studies in ADHD.Hum Genet. 2009 Jul;126(1):13-50. doi: 10.1007/s00439-009-0663-4. Epub 2009 Apr 22. Hum Genet. 2009. PMID: 19384554 Free PMC article. Review.
Cited by 166 articles
Behavior and Molecular Genetic Approaches to Comorbidity.Curr Dev Disord Rep. 2019 Jun;6(2):31-36. doi: 10.1007/s40474-019-00162-0. Epub 2019 May 18. Curr Dev Disord Rep. 2019. PMID: 32042548
Attention-Deficit Hyperactivity Disorder Across the Lifespan.Focus (Am Psychiatr Publ). 2016 Jan;14(1):46-53. doi: 10.1176/appi.focus.20150022. Epub 2015 Dec 24. Focus (Am Psychiatr Publ). 2016. PMID: 31975793 Free PMC article.
Examining overlap and homogeneity in ASD, ADHD, and OCD: a data-driven, diagnosis-agnostic approach.Transl Psychiatry. 2019 Nov 26;9(1):318. doi: 10.1038/s41398-019-0631-2. Transl Psychiatry. 2019. PMID: 31772171 Free PMC article.
HOPS: a quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases.Genome Biol. 2019 Oct 25;20(1):222. doi: 10.1186/s13059-019-1844-7. Genome Biol. 2019. PMID: 31653226 Free PMC article.
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2019 Jun 21;6(6):CD008223. doi: 10.1002/14651858.CD008223.pub3. Cochrane Database Syst Rev. 2019. PMID: 31222721
- U01 MH085518/MH/NIMH NIH HHS/United States
- R01 MH058277-03/MH/NIMH NIH HHS/United States
- R01 MH062873/MH/NIMH NIH HHS/United States
- U01 MH085515/MH/NIMH NIH HHS/United States
- R01 MH058277/MH/NIMH NIH HHS/United States
- R01MH080403/MH/NIMH NIH HHS/United States
- K23MH066275-01/MH/NIMH NIH HHS/United States
- R01 MH062873-03/MH/NIMH NIH HHS/United States
- R13 MH059126/MH/NIMH NIH HHS/United States
- K23 MH066275/MH/NIMH NIH HHS/United States
- R01MH62873/MH/NIMH NIH HHS/United States
- R13MH059126/MH/NIMH NIH HHS/United States
- U01MH085518/MH/NIMH NIH HHS/United States
- R01 MH081803/MH/NIMH NIH HHS/United States
- R01 MH058277-04/MH/NIMH NIH HHS/United States
- R13 MH059126-09/MH/NIMH NIH HHS/United States
- R01MH081803/MH/NIMH NIH HHS/United States
- R01 MH062873-05/MH/NIMH NIH HHS/United States
- R01MH58277/MH/NIMH NIH HHS/United States
- K23 MH066275-01A1/MH/NIMH NIH HHS/United States
- U01MH085515/MH/NIMH NIH HHS/United States
- R01 MH083823/MH/NIMH NIH HHS/United States
- R13 MH059126-10/MH/NIMH NIH HHS/United States
- R01 MH058277-05/MH/NIMH NIH HHS/United States
- R01 MH080403/MH/NIMH NIH HHS/United States
- R01 MH062873-01A1/MH/NIMH NIH HHS/United States
- R01 MH062873-02/MH/NIMH NIH HHS/United States
- R01 MH058277-02/MH/NIMH NIH HHS/United States
- U01 MH085518-01/MH/NIMH NIH HHS/United States
- G0801418/Medical Research Council/United Kingdom
- Wellcome Trust/United Kingdom
- R01 MH062873-04/MH/NIMH NIH HHS/United States
- U01 MH085515-01/MH/NIMH NIH HHS/United States